EU-European Union drug regulators have begun investigating the new coronavirus vaccine developed by American pharmaceutical giant Johnson & Johnson, citing multiple cases of confirmed blood clots after vaccination. Clarified.
On the other hand, "it is unknown at this stage whether there is a relationship between vaccination and blood clots."
EMA = European Pharmaceutical Agency reported on the 9th that after vaccination with the new coronavirus developed by Johnson & Johnson, it was confirmed that a blood clot, a blood clot, was formed and blood vessels were clogged. Announced that it has begun an investigation.
There have been four reports of severe thrombosis with platelet depletion, one in clinical trials and three in the United States, where vaccination began last month, one of which died.
"At this stage, it is unclear if there is a connection between vaccination and blood clots," the EMA said.
According to the EMA, the vaccine is currently used only in the United States under an emergency use authorization, and although it has been licensed in the EU, vaccination has not yet begun.
Regarding the vaccine for the new coronavirus, EMA announced on the 7th of this month the results of a survey that there may be a relationship between the vaccine developed by AstraZeneca and others and blood clots, and measures such as setting age restrictions in each country have been taken one after another. is.